Get started
Author

Michelle L. VanLith

Observed names: M L VanLith, M VanLith, M. L. VanLith, Michelle L VanLith, Michelle VanLith, VanLith, Michelle L
OpenAlex ID: A5042094086
Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model.
1998 · G J Rowse, R M Tempero, et al. · PubMed · 202
The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis
2006 · N Moniaux, C Nemos, et al. · Oncogene · 88
CD4+ Lymphocytes Provide MUC1-Specific Tumor Immunity In Vivo That Is Undetectable In Vitro and Is Absent in MUC1 Transgenic Mice
1998 · Richard M Tempero, Michelle L VanLith, et al. · The Journal of Immunology · 65
PDF
Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1)
2004 · Karl G. Kohlgraf, Andrew J. Gawron, et al. · Cancer Immunology Immunotherapy · 33
MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses
2002 · M. L. VanLith · International Immunology · 19
Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines
2002 · Connie Sivinski, Karl Kohlgraf, et al. · Cancer Immunology Immunotherapy · 17
Paraneoplastic Autoimmune Reactions
1999 · Connie L. Sivinski, Richard M. Tempero, et al. · Humana Press eBooks · 2
Works count: 8
Citation count: 426
H-index: 6
I10-index: 6
Year
Topic
Type